Yes You Health.
Shaping the future of B2B
in the pharmaceutical industry.
Together with you.

Partner with Farmaprojects,
the global B2B hub of Polpharma Group.

Our end-to-end involvement in the product life cycle ensures that each product receives the attention and care it deserves, from ideation to maturity. With our dedicated portfolio team guiding the way, Farmaprojects aims to maximize the value of all commercialized products in order to satisfy your strategic needs and growth goals.

Farmaprojects in numbers

80+

launches performed per year

1,000+

MA approvals in the last decade

30+

years of experience

Polfarma in numbers

€1.2bn

FY 2023 revenue

7

manufacturing plants

5

R&D centers

Our Portfolio

Yes to value creation in generics. Discover our strategic portfolio

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

People

Meet our Yes People.
Culture shaping the future of B2B

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Research & Development

Our global R&D.
The backbone for your success

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

W

Willpower

The will to make things happen: overcoming barriers, being relentless and being disruptive to change and improve the world of health.

W

Welcoming

Cherishing the essential role of people in our industry, from customers to patients, and spread optimism and honesty, as well as openness to creative business models.

W

Wow

Delivering products and services that exceed your expectations through the highest expertise and our innovative perspective towards B2B.

Farmaprojects in numbers

Your professional development

Your work-life balance

Your health

Ready to grow? Meet an agile team with the power of a European market leader

Farmaprojects is the B2B hub of Polpharma Group, the biggest pharmaceutical laboratory in Poland. We combine a powerful and agile team of 50+ people with the manufacturing and developing capabilities of a European market leader to provide you with the best-in-class B2B services and products.

As a privately owned company, our priority is building a strategic and long-term partnership with you and your team. Here’s how we make it happen: you can benefit from high cost-efficiency advantages through our vertical integration, you can rely on a solid financial group with leading R&D capabilities to enhance your development, and you can expand on a global level through our presence in more than 100 countries.

Our core business is out-licensing and distribution models, but together we can go further: new business models, co-development opportunities, early-stage licensing or complex product development… Say YES to your growth.

We maximize the value of your products with our end-to-end approach

Our end-to-end involvement in the product life cycle ensures that each product receives the attention and care it deserves, from ideation to maturity. With our dedicated portfolio team guiding the way, Farmaprojects aims to maximize the value of all commercialized products in order to satisfy your strategic needs and growth goals.

From the early stages of ideation up until nomination, we focus on selecting products with the greatest potential for success. This involves rigorous market analysis, understanding customer needs, and identifying gaps in the market where the product can fulfill a valuable role. Once a product is selected, Farmaprojects engages in thorough project development
processes, leveraging cutting-edge technologies and methodologies to ensure a successful commercial launch and roll-out. We monitor the product’s performance in the market throughout the whole product life cycle, gathering feedback from customers and identifying areas for optimization.

1. Ideation

What will the market need in the future?

2. Nomination

Which products are feasible and best serve our customer’s and partner’s needs?

3. Project developmnent

Which strategic product plan best fits the project and the customer needs?

4. Launch & roll-out

How should we design the first wave launch? How can we improve subsequent launches?

5. Life cycle management

How can we respond to changing customer needs? How can we maximize value?

Backed by Polpharma, driven by your needs

Working with Farmaprojects means leveraging the state-of-the-art manufacturing and R&D potential of a European market leader like Polpharma. As one of the 20 biggest manufacturers of generic drugs worldwide and over 80 years of history, we produce 400 millions medicine packages every year covering the whole value chain from API manufacturing to commercialization and serving all 5 continents.
With 5 R&D centers, the Polpharma Group is currently developing more than 260 products, from which more than 100 are FDFs. In the Gdansk Science and Technology Park, we have established one of the most modern biotechnology labs in Poland. This is where we develop biological drugs, the future of pharmacotherapy.

Polpharma Group in numbers

Top4

CHC company in CEE + Eurasia

€1.2bn

FY 2023 revenue

7

manufacturing plants

>7.200

employees

Research and development at Polpharma Group

5

R&D centers

233.4m

R&D spending

109

development projects in FDF

17

patents obtained

Beyond out-licensing.
Shaping the future of B2B together with you

Our commitment to deliver the best B2B services and products goes hand in hand with defining new ways of partnering beyond out licensing.

New business models

For example, sub-licensing a product in other territories

Development opportunities

Joint developments with partners and suppliers to expand into new territories

Early-stage licensing

Leveraging early opportunities: License and supply contracts

Complex products

We nominate new complex products every year, especially value added medicines

Reach out, we’re always listening.

Polpharma Group in numbers

€1.2bn

FY 2023 revenue

Top4

CHC company in CEE + Eurasia

>7.200

employees

7

manufacturing plants

Reach out, we’re always listening.